FDA Device Intelligence
HomeBERKELEY ADVANCED BIOMATERIALS, LLC › K2M VENADO HA/TCP Cancellous Granules

K2M VENADO HA/TCP Cancellous Granules

BERKELEY ADVANCED BIOMATERIALS, LLC · Model 4815-T6060 · UDI-DI 00816125021628

MQV Prescription
1
510(k) clearances
2,073
Adverse events (45 deaths)
120
Recalls
225
Facilities

Description

VENADO Granules Bone Graft System is a sterile bone graft comprised of Bi-Ostetic (60% hydroxyapatite and 40% beta-tri-calcium phosphate) granules. These materials have been the topic of extensive clinical studies for a several decades. VENADO Granules are safe and have excellent biocompatibility. After it is implanted, the implant resorbs and is later replaced by natural bone. VENADO Granules are a natural choice for sparing patients the trauma of autograft harvesting. It also provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission. VENADO Granules are an osteoconductive bone substitute shaped as granules that are intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium. The granules may be pressed into the void or into the surgical site by hand. The VENADO Granules provide void filling material that acts as a temporary support medium. The granules are not intended to provide structural support during the healing process. The implant is radio-opaque. VENADO Granules are biocompatible and resorbs in the body as bone ingrowth occurs.

Recalls

DateFirmReason
2026-07-02IsoTis OrthoBiologics, Inc.Demineralized bone matrix (DBM) in resorbable mesh indicated for use with autograft as a bone graft extender in the posterolateral spine and pelvis, were filled with approx. 4.5 cc
2026-03-25Orthorebirth Co LtdResorbable bone void filler falls outside standard specifications.
2026-03-25Orthorebirth Co LtdResorbable bone void filler falls outside standard specifications.
2026-03-09XTANT Medical Holdings, IncProducts were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.
2025-09-02Berkeley Advanced Biomaterials, LLCDue to incorrect product label (Incorrect product name identified on outer packaging).
2025-04-07SCIENCE & BIO MATERIALSVials of implant bone granules may contain less product then specified on labeling.
2024-11-27IsoTis OrthoBiologics, Inc.Hydration issue resulting in the product being less cohesive and moldable than intended due to an issue with the polymer.
2024-11-27IsoTis OrthoBiologics, Inc.Incorrect expiration date listed on the outer box, which does not align with the correct expiration date listed on the inner tray.
2023-12-22Musculoskeletal Transplant Foundation, Inc.Filling process qualification did not demonstrate adequate process capability. Possible consequences include extended surgery time due to extrudability issues.
2023-12-22Musculoskeletal Transplant Foundation, Inc.Filling process qualification did not demonstrate adequate process capability. Possible consequences include extended surgery time due to extrudability issues.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.